Emu oil is rendered from emu fat (Dromaius novaehollandiae) and contains a unique fatty acid profile: ~42% oleic acid, 21% linoleic, 11% palmitic, plus traces of omega-3s. Our research shows the TOPICAL use has the strongest evidence — it reduces inflammation comparable to ibuprofen gel in two animal studies, promotes wound healing, and has exceptional skin penetration due to its fatty acid ratios. Oral emu oil has minimal clinical data. The anti-inflammatory effects appear mediated by oleic acid's NF-κB inhibition combined with unique ratios of omega-6/omega-9 that mirror human skin lipids. Evidence base is small — mostly Australian studies funded by the emu oil industry.
Topical: Emu oil penetrates skin effectively because its fatty acid ratios (oleic:linoleic:palmitic) closely match human stratum corneum lipids — it's "biomimetic." Once in tissue, oleic acid inhibits NF-κB, reducing local inflammatory cytokine production. The combination of omega-6 and omega-9 fatty acids modulates prostaglandin production locally. Oral: Oleic acid + linoleic acid contribute to general anti-inflammatory effects, but oral bioavailability studies for therapeutic fatty acid levels are lacking.
No significant drug interactions identified for topical or oral emu oil.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.